AFP and hepatocellular carcinoma: This model has an AUROC of 0.970 and a true positive rate of 89% for detecting ANHC and early-stage HCC patients, whereas the AUROC of AFP was 0.597 with a true positive rate of 0% at a 5% false positive rate and presented better diagnostic performance compared with their previous model based on simple clinical metrics.